Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mining the internet for drug information

Nigam Shah1

  • 1Stanford University School of Medicine, Stanford, California.

Clinical Advances in Hematology & Oncology : H&O
|July 9, 2014
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenges in AI Based Tumor Board Case Summarization and Recommendations.

Research square·2026
Same author

A S.C.O.R.E. framework for evaluating open-ended responses from large language models in healthcare.

Cell reports. Medicine·2026
Same author

STARC-9: A Large-scale Dataset for Multi-Class Tissue Classification for CRC Histopathology.

Advances in neural information processing systems·2026
Same author

STARC-9: A Large-scale Dataset for Multi-Class Tissue Classification for CRC Histopathology.

ArXiv·2026
Same author

PRIMARY-AI: outcomes-based standards to safeguard primary care in the AI era.

Nature medicine·2026
Same author

Key takeaways from Stanford's symposium on AI for Data Science.

Journal of clinical and translational science·2025
Same journal

Clinical response with cabozantinib plus nivolumab, a first-line therapy in advanced renal cell carcinoma: a clinical case report.

Clinical advances in hematology & oncology : H&O·2026
Same journal

Active treatment in high-risk, early-stage CLL or SLL.

Clinical advances in hematology & oncology : H&O·2026
Same journal

Targeting human kallikrein 2 in prostate cancer.

Clinical advances in hematology & oncology : H&O·2026
Same journal

Targeting BRAF V600E mutations in metastatic colorectal cancer.

Clinical advances in hematology & oncology : H&O·2026
Same journal

The development of second-generation KRAS inhibitors.

Clinical advances in hematology & oncology : H&O·2026
Same journal

Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.

Clinical advances in hematology & oncology : H&O·2026
See all related articles